You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復宏漢霖(02696.HK):TGA批准漢曲優®用於治療早期乳腺癌、局部晚期乳腺癌、轉移性乳腺癌及晚期胃癌
格隆匯 07-25 17:57

格隆匯7月25日丨復宏漢霖(02696.HK)發佈公吿,近日,Cipla Australia Pty Ltd(公司商務合作伙伴Cipla Limited的子公司)收到相關注冊證書,澳大利亞藥品管理局(“TGA”)已批准150mg/瓶規格漢曲優® (注射用曲妥珠單抗)用於治療(1)HER2陽性的早期乳腺癌、(2)HER2陽性的局部晚期乳腺癌、(3)HER2過表達的轉移性乳腺癌、及(4)HER2陽性的晚期胃腺癌或胃食管交界腺癌,其於澳大利亞獲批的商品名為Tuzucip®和Trastucip®。 

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account